An estimated 25 per cent of R&D budgets are now being spent on externalisation, it is crucial to develop strategic and effective business models and determine how best to outsource the different processes of drug discovery.
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharmaceutical Launch Excellence Summit
1 - 3 December, 2026
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange Europe
22 - 23 February 2027
Leonardo Royal Hotel Amsterdam, Netherlands
Register Now |
View Agenda |
Learn More
Pharma Contract Manufacturing
9 - 11 March 2027
Berlin, Germany
Register Now |
View Agenda |
Learn More